Literature DB >> 24817950

Expression of Hsp90α and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.

Tingyuan Huang1, Size Chen2, Hongyu Han3, Huadan Li1, Zhizhou Huang1, Jianming Zhang1, Qiangbin Yin1, Xiaojie Wang1, Xiaojiao Ma1, Peijuan Dai1, Danping Duan1, Fei Zou1, Xuemei Chen1.   

Abstract

Hsp90α (heat shock protein 90α), one of the important molecular chaperones in cancer cell signal transduction, has been a new candidate target for cancer therapy. Cyclin B1, the client protein of Hsp90α, plays a key role as a mitotic cyclin in the G2-M phase transition during the cell cycle progression. However, the relationship between the level of HSP90α and cyclin B1, the location of Hsp90α and cyclin B1 in prognosis of esophageal squamous cell carcinoma (ESCC) has not been examined. Here, we demonstrate that the diagnostic significance of Hsp90α and cyclin B1 by immunohistochemistry and the association of Hsp90α and cyclin B1 expression in ESCC. In the specimens from 105 ESCC patients (81 stained with Hsp90α antibody by Immunohistochemistry, 65 with cyclin B1 antibody, and among them, 41 paired specimens were stained with Hsp90α and cyclin B1 respectively, and then checked for the correlation of the level and location of Hsp90α and cylcin B1. The positivity rate of Hsp90α and cyclin B1 expression were 96.3% (78 of 81) and 84.6% (55 of 65) respectively. Both of them, the expression levels are associated with the clinical pathological stage (Hsp90α, p=0.027; cyclin B1, p=0.007). No association was found between Hsp90α or cyclin B1 and gender, age, tumor location. As to TMN stage, there is no association with the level of Hsp90α, However, cyclin B1 expression is significantly related to tumor status (p=0.002). Interestingly, Hsp90α expression was negatively correlated to cyclin B1 expression (Gamma=-0.692, p=0.007) in the keratin pearls though there is a positive correlation in the other areas of tumor (Gamma=0.503, p=0.015), which suggest Hsp90α might play diverse roles in the cyclin B1 expression and cyclin B1 related cell cycle regulation in the different area of tumor. These findings demonstrated that the expression of Hsp90α, cyclin B1 protein is associated with tumor malignancy and prognosis for patients with human esophageal squamous cell carcinoma, and Hsp90α might be involved in cyclin B1 expression regulation and cell cycle regulation in keratin peal formation of ESCC.

Entities:  

Keywords:  Hsp90α; cyclin B1; esophageal squamous cell carcinoma; immunohistochemistry; keratin pearl; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24817950      PMCID: PMC4014234     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  40 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

2.  Beta-catenin expression is altered in human colonic aberrant crypt foci.

Authors:  X P Hao; T G Pretlow; J S Rao; T P Pretlow
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.

Authors:  A J Janss; A Maity; C B Tang; R J Muschel; W G McKenna; L Sutton; P C Phillips
Journal:  Neuro Oncol       Date:  2001-01       Impact factor: 12.300

4.  Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.

Authors:  Tadahiro Nozoe; Daisuke Korenaga; Akira Kabashima; Takefumi Ohga; Hiroshi Saeki; Keizo Sugimachi
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

5.  Hemophagocytosis-mediated keratinization in oral carcinoma in situ and squamous cell carcinoma: a possible histopathogenesis of keratin pearls.

Authors:  Kamal Al-Eryani; Jun Cheng; Tatsuya Abé; Manabu Yamazaki; Satoshi Maruyama; Masayuki Tsuneki; Ahmed Essa; Hamzah Babkair; Takashi Saku
Journal:  J Cell Physiol       Date:  2013-10       Impact factor: 6.384

6.  Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.

Authors:  M Lauten; C Beger; K Gerdes; G Asgedom; C Kardinal; K Welte; M Schrappe
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

7.  Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells.

Authors:  Juping Yuan; Ruilan Yan; Andrea Krämer; Frank Eckerdt; Marc Roller; Manfred Kaufmann; Klaus Strebhardt
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

8.  Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.

Authors:  James A Koziol; Jian-Ying Zhang; Carlos A Casiano; Xuan-Xian Peng; Fu-Dong Shi; Anne C Feng; Edward K L Chan; Eng M Tan
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

9.  The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells.

Authors:  Jianjun Zhang; Zhichao Zheng; Yan Zhao; Tao Zhang; Xiaohu Gu; Wei Yang
Journal:  Clin Exp Med       Date:  2012-09-07       Impact factor: 3.984

10.  High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.

Authors:  Jiahong Wang; Shuzhong Cui; Xiangliang Zhang; Yinbing Wu; Hongsheng Tang
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

View more
  17 in total

1.  Modification of HSP proteins and Ca2+ are responsible for the NO-derived peroxynitrite mediated neurological damage in PC12 cell.

Authors:  Jun Wen; Hua Li; Yudan Zhang; Xia Li; Fang Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Gene expression profile of human esophageal squamous carcinoma cell line TE-1.

Authors:  Hong-Xing Cai; Zheng-Qiu Zhu; Xiao-Ming Sun; Zhou-Ru Li; Yan-Bo Chen; Guo-Kai Dong
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo.

Authors:  Yi-Wen Wu; Min-Wu Chao; Huang-Ju Tu; Liang-Chieh Chen; Kai-Cheng Hsu; Jing-Ping Liou; Chia-Ron Yang; Shih-Chung Yen; Wei-Chun HuangFu; Shiow-Lin Pan
Journal:  Oncogenesis       Date:  2021-05-13       Impact factor: 7.485

4.  The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis.

Authors:  Yong Wen; Lei Cao; Wen-Ping Lian; Guo-Xia Li
Journal:  Oncotarget       Date:  2017-09-26

5.  Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.

Authors:  Helga Weber; José R Valbuena; Mustafa A Barbhuiya; Stefan Stein; Hana Kunkel; Patricia García; Carolina Bizama; Ismael Riquelme; Jaime A Espinoza; Stephen E Kurtz; Jeffrey W Tyner; Juan Francisco Calderon; Alejandro H Corvalán; Manuel Grez; Akhilesh Pandey; Pamela Leal-Rojas; Juan C Roa
Journal:  Oncotarget       Date:  2017-04-18

6.  Prognostic role of cyclin B1 in solid tumors: a meta-analysis.

Authors:  Chenyang Ye; Ji Wang; Pin Wu; Xiaofen Li; Ying Chai
Journal:  Oncotarget       Date:  2017-01-10

7.  Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis.

Authors:  Xiaohua Chen; Sina Cai; Baoxia Li; Xiaona Zhang; Wenhui Li; Henglun Linag; Xiaolong Cao
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

Review 8.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

9.  The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis.

Authors:  Xiao-wei Wang; Xin-hui Shi; Yu-suo Tong; Xiu-feng Cao
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

10.  Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis.

Authors:  Hua Ge; Yan Yan; Lingfei Guo; Fei Tian; Di Wu
Journal:  Onco Targets Ther       Date:  2018-01-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.